Diffuse intrahepatic biliary strictures in sarcoidosis resembling sclerosing cholangitis: Case report and review of the literature

Digestive Diseases and Sciences

Volumn 42, Issue 6, 1997, Pages 1295-1301

  Alam, Imtiaz ^a   Levenson, Scott D ^a   Ferrell, Linda D ^a   Bass, Nathan M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cholestasis; Corticosteroid; Granulomas; Sarcoidosis; Treatment

Indexed keywords

CORTICOSTEROID;

ADULT; ARTICLE; BILE DUCT OBSTRUCTION; CASE REPORT; CHOLANGIOGRAPHY; CHOLESTASIS; CORTICOSTEROID THERAPY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENTERITIS; FEMALE; HUMAN; PRIORITY JOURNAL; SARCOIDOSIS; SCLEROSING CHOLANGITIS;

ADULT; BILE DUCTS, INTRAHEPATIC; BIOPSY; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGITIS, SCLEROSING; CHOLESTASIS, INTRAHEPATIC; FEMALE; HUMANS; PREDNISONE; SARCOIDOSIS;

EID: 0030873192     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018874612166     Document Type: Article

References (45)

1. Chesnutt AN: Enigmas in sarcoidosis. West J Med 162:519-526, 1995
2. Lehmuskallio E, Hannuksela M, Halme H: The liver in sarcoidosis. Acta Med Scand 202:289-293, 1977
3. Mayock RI, Bertrand P, Morrison CE, Scott JH: Manifestations of sarcoidosis - analysis of 145 patients, with review of nine series selected from the literature. Am J Med 35:67-89, 1963
4. Klatskin G, Yesner R: Hepatic manifestations of sarcoidosis and other granulomatons diseases. Yale J Biol Med 23:207-248, 1950
5. Maddrey WC, Johns CJ, Boitnott JK, Iber KL: Sarcoidosis and chronic hepatic disease: A clinical and pathologic study of 20 patients. Medicine (Baltimore) 49:375-395, 1970
6. Shay II, Berk JE, Sons M, Aegerter E, Weston JK, Adams AB: The liver in sarcoidosis. Gastroenterology 19:441-459, 1951
7. Devaney K, Goodman ZD, Fpstein MS, Zimmerman HJ, Ishak KG: Hepatic sarcoidosis: Clinicopathologic features in 100 patients. Am J Surg Pathol 17:1272-1280, 1993
8. Rudzki C, Ishak KG, Zimmerman HJ: Chronic intrahepatic eholestasis of sarcoidosis. Am J Med 59:373-387, 1975
9. Thomas E, Micci D: Chronic intrahepatic cholestasis with granulomas and biliary cirrhosis. JAMA 238:337-338, 1977
10. Nakanuma Y, Ohta G, Yamazaki Y: Intrahepatic bile duct destruction in a patient with sarcoidosis and chronic intrahepatic cholestasis. Acta Pathol Jpn 29:211-215, 1979
11. Bass NM, Burroughs AK, Scheuer PJ, James DG, Sherlock S: Chronic intrahepatic cholestasis due to sarcoidosis. Gut 23:417-421, 1982
12. Hughes JS, Yash KP, O'Brien TF: Sarcoidosis presenting as biliary cirrhosis: Treatment with chlorambucil. South Med J 76:1440-1442, 1483
13. Pereira-Lima J, Schaffner F: Chronic cholestasis in hepatic sarcoidosis with clinical features resembling primary biliary cirrhosis. Am J Med 83:144-148, 1987
14. Jouanolle H, Turlin B, Guyader D, Deugnier Y, Brissot P: Association of sarcoidosis and primary biliary cirrhosis: Review of the literature apropos of a new case. Rev Med Interne 11:252-255, 1990
15. Murphy JR, Sjogren MH, Kikendall JW, Peura DA, Goodman Z: Small bile duct abnormalities in sarcoidosis. J Clin Gastroenterol 12:555-561, 1990
16. Wiesner RH: Current concepts in primary sclerosing cholangitis. Mayo Clin Proc 69:969-982, 1994
17. Lee Y-M, Kaplan MM: Primary selerosing cholangitis. N Engl J Med 332:924-933, 1995
18. Broome U, Glaumann H, Hellers G, Nilsson B, Sorstad J, Hultcrantz R: Liver disease in ulcerative colitis: An epidemiological and follow up study in the county of Stockholm. Gut 35:84-89, 1994
19. Boberg KM, Schrumpf E, Fausa O, Elgjo K, Kolmannskog F, Haaland T, Holter E: Hepatobiliary disease in ulcerative colitis. An analysis of 18 patients with hepatobiliary lesions classified as small-duct primary sclerosing cholangitis. Scand J Gastroenterol 29:744-752, 1994
20. Heully F, Bessot M, Gaucher P, Vicari F, Laurent J, Dossmann J: Les cholangites primitives. Arch Fr Mal Appar Dig 58:757-772, 1969
21. Thompson HH, Pitt HA, Tompkins RK, Longmire WC: Primary sclerosing cholangitis. A heterogenous disease. Ann Surg 196:127-136, 1982
22. Schep GN, Scully LJ: Primary sclerosing cholangitis and sarcoidosis: An unusual combination. Case report and review of the literature. Can J Gastroenterol 4:489-494, 1990
23. Ilan Y, Rappaport I, Feigin R, Ben-Chetrit E: Primary sclerosing cholangitis in sarcoidosis. J Clin Gastroenterol 16:326-328, 1993
24. Van Steenbergen W, Fevery J, Vandenbrande P, Desmet V, Ponette E, Kerremens R, de Groote J: Ulcerative colitis, primary sclerosing cholangitis, bile duct carcinoma, and generalized sarcoidosis. J Clin Gastroenterol 9:574-579, 1987
25. Theodoropoulos G, Archimandritis A, Davaris P, Plataris J, Melissinos K: Ulcerative colitis and sarcoidosis: A curious association - report of a case. Dis Colon Rectum 24:308-310, 1981
26. Barr GD, Shale DJ, Jewell DP: Ulcerative colitis and sarcoidosis. Postgrad Med J 86:618-619, 1986
27. Fries W, Grassi A, Leone L, Giacomin D, Galeazzi F, Naccarato R, Martin A: Association between inflammatory bowel disease and sarcoidosis. Report of two cases and review of the literature. Scand J Gastroenterol 30:1221-1223, 1995
28. Valla D, Pessegueiro MH, Degott C, Lebrec D, Rueff B, Benhamou JP: Hepatic sarcoidosis with portal hypertension. A report of seven cases with a review of the literature. Q J Med 63:531-544, 1987
29. Casavilla FA, Gordon R, Wright HI, Gavaler JS, Starzl TE, Van Thiel DH: Clinical course after liver transplantation in patients with sarcoidosis. Ann Intern Med 118:865-866, 1993
30. Folz SJ, Johnson D, Swensen SJ: Abdominal manifestations of sarcoidosis in CT studies. J Comput Assist Tomogr 19:573-579, 1995
31. Ludwig J, Colina F, Poterucha JJ: Granulomas in primary sclerosing cholangitis. Liver 15:307-312, 1995
32. Ludwig J, Czaja AJ, Dickson ER, LaRusso NF, Weisner RH: Manifestations of nonsupprative cholangitis in chronic hepatobiliary diseases: Morphologic spectrum, clinical correlations and terminology. Liver 4:105-116, 1984
33. Lo SK, Fleming KA, Chapman RW: A 2-year follow-up study of anti-neutrophil antibody in primary sclerosing cholangitis: Relationship to clinical activity, liver biochemistry and ursodeoxycholic acid treatment. J Hepatol 21:974-978, 1994
34. Seibold F, Weber P, Klein R, Berg PA, Weidman KH: Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut 33:657-662, 1992
35. Haagsma EB, Mulder AHL, Gouw ASH, Horst G, Meerman L, Slooff MJH, Kallenberg CGM: Neutrophil cytoplasmic autoantibodies after liver transplantation in patients with primary sclerosing cholangitis. J Hepatol 19:8-14, 1993
36. Weisner RH, Ludwig J, La Russo NF, MacCarty RL: Diagnosis and treatment of primary sclerosing cholangitis. Semin Liver Dis 5:241-253, 1985
37. Chapman RW, Arborgh BA, Rhodes JM, Summerfield JA, Dick R, Scheur PJ, Sherlock S: Primary sclerosing cholangitis - a review of its clinical features, cholangiography and hepatic histology. Gut 21:870-877, 1980
38. Aadland E, Schrumpf E, Fausa O, Elgjo K, Heilo A, Aakhus T, Gjone E: Primary sclerosing cholangitis: A long-term follow-up study. Scand J Gastroenterol 22:655-664, 1987
39. Escorsell A, Parés A, Rodés J, Solís-Hérruzo J, Miras M, de la Morena E: Epidemiology of primary sclerosing cholangitis in Spain. J Hepatol 21:787-791, 1994
40. Hedfors E, Moller E: HLA antigens in sarcoidosis. Tissue Antigens 3:95-98, 1972
41. Humminghake WG, Crystal RG: Pulmonary sarcoidosis. A disorder mediated by excess helper T-lymphocytes activity at sites of disease activity. N Engl J Med 305:429-434, 1981
42. Schrumpf E, Fausa O, Forre O, Dobloug JH, Ritland S, Throsby E: HLA antigens and immunoregulatory T-cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol 17:187-191, 1982
43. Chapman RW, Varghese Z, Gaul R, Patel G, Kokinon N, Sherlock S: Association of primary sclerosing cholangitis with HLA-B8. Gut 28:38-41, 1983
44. Chapman RW, Cottone M, Selby WS, Shepherd HA, Sherlock S, Jewell DP: Serum auto antibodies, ulcerative colitis and primary sclerosing cholangitis. Gut 27:86-91, 1986
45. Tozman EC: Sarcoidosis: Clinical manifestations, epidemiology, therapy, and pathophysiology. Curr Opin Rheumatol 3:155-159, 1991